# Quantifying Disease Progression in LBSL

> **NCT05750979** · — · UNKNOWN · sponsor: **M. Engelen** · enrollment: 20 (estimated)

## Conditions studied

- LBSL
- Leukoencephalopathies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05750979
- **Lead sponsor:** M. Engelen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-11
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750979, "Quantifying Disease Progression in LBSL". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05750979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*